Literature DB >> 17560042

Dexamethasone transiently attenuates up-regulation of endostatin/collagen XVIII following traumatic brain injury.

Z-Y Zhang1, Z Zhang, U Fauser, M Artelt, M Burnet, H J Schluesener.   

Abstract

Endostatin/collagen XVIII is a specific inhibitor of endothelial proliferation and migration in vitro. It has also been shown to have anti-angiogenic activity and tumor growth inhibitory activity in vivo and in vitro. Here we studied expression of endostatin/collagen XVIII in a rat traumatic brain injury (TBI) model, focusing on the early phase. A significant up-regulation of endostatin/collagen XVIII in TBI began as early as 24 h post-TBI. Double-staining experiment revealed that the major resource of endostatin/collagen XVIII(+) cells in our TBI rat model was a subpopulation of reactivated microglia/macrophages. Our data further showed that dexamethasone attenuated up-regulation of endostatin/collagen XVIII expression at days 1 and 2, but not at day 4, post-TBI, indicating that dexamethasone might possess an early and transient influence to the angiogenesis following TBI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560042     DOI: 10.1016/j.neuroscience.2007.04.052

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.

Authors:  Yongqi Li; Dalian Ding; Haiyan Jiang; Yong Fu; Richard Salvi
Journal:  Neurotox Res       Date:  2011-04-01       Impact factor: 3.911

2.  Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitro.

Authors:  Abraham Al Ahmad; Boyeon Lee; Jonathan Stack; Christi Parham; Joel Campbell; Douglas Clarke; Andrzej Fertala; Gregory J Bix
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

3.  Endostatin/collagen XVIII is increased in cerebrospinal fluid after severe traumatic brain injury.

Authors:  Hao Chen; Li-Xia Xue; He-Li Cao; Shi-Wen Chen; Yan Guo; Wen-Wei Gao; Shi-Ming Ju; Heng-Li Tian
Journal:  Biomed Res Int       Date:  2013-09-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.